Pericardial Access With ViaOne Device

Last updated: January 8, 2025
Sponsor: CardioVia
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

N/A

Treatment

ViaOne device

Clinical Study ID

NCT05006157
CAV-CL-011
  • Ages > 21
  • All Genders

Study Summary

ViaOne device is a tool designed to allow percutaneous subxiphoid pericardial access utilizing a proprietary mechanism of entry into the pericardial sac. In this study ViaOne will be used to obtain pericardial access in patients in whom electrophysiological diagnostic (mapping) and/or therapeutic (ablation) of epicardial sites via percutaneous subxiphoid approach to the to the normal, non-distended pericardial space is indicated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age > 21

  2. Electrophysiological diagnostic (mapping) and/or therapeutic (ablation) ofepicardial sites via percutaneous subxiphoid approach to the to the normal,non-distended ericardial space is indicated.

  3. Pre-treatment coagulation values within the following limits:

  • international normalized ratio 0.8 - 1.2

  • partial thromboplastin time 25 - 35''

  1. Pre-treatment hematology and biochemistry values within the following limits:

  • hemoglobin ≥ 10 g/dL (g/100 mL)

  • platelets ≥ 150 x 10^9/L (x 10^3/mm^3)

  • white blood cells ≥ 3.0 x 10^9/L (x 10^3/mm^3)

  • absolute neutrophil count (ANC) ≥ 1.5 x 10^9/L (1.5 x 10^3/mm^3)

  • serum creatinine < 1.5 mg/dL

  • aspartate aminotransferase < 1.5 x ULN (upper limit of norm)

  • alanine aminotransferase < 1.5 x ULN

  • alkaline phosphatase < 1.5 x ULN

  1. Signed informed consent.

Exclusion

Exclusion Criteria:

  • History of cardiac or pericardial surgery or prior pericardial ablation.

  • History of chronic pericarditis.

  • Known pericardial fibrosis and/or adhesions.

  • Any anomaly in the chest anatomy.

  • Myocardial infarction, past or present.

  • Bleeding disorders.

  • Hepatic enlargement.

  • BMI > 40

  • Participation in another interventional trial.

  • Pregnancy.

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: ViaOne device
Phase:
Study Start date:
July 10, 2021
Estimated Completion Date:
June 30, 2025

Study Description

The primary objective of the study is to provide evidence of safety of ViaOne in obtaining percutaneous subxiphoid approach to the pericardial space. The secondary objective is to provide initial estimate of efficacy of ViaOne in obtaining percutaneous subxiphoid approach to the pericardial space.

Screening procedures will include laboratory analyses of the complete blood count, serum chemistry, coagulation parameters, and urine or serum ß-HCG test.A physical examination and collection of vital signs will be conducted. Medical history data and information on concomitant medications will be collected.

Once eligibility is verified, subjects will be scheduled for a procedure during which percutaneous subxiphoid pericardial access will be obtained using the ViaOne and its associated procedure. Time period between the study device insertion through the subxiphoid incision and guidewire insertion into the pericardial sac, overall time in procedure, and any procedural complications and device deficiencies will be recorded.

Follow-up visit will be conducted as part of the planned protocol procedures at up 5 ± 1 days after the procedure or at the time of discharge, whichever comes first. The visit will include evaluation of any adverse events and complications. Length of hospital stay will be recorded, where the discharge precedes or coincides with the final follow-up visit of the study.

Connect with a study center

  • Hadassah Ein Kerem MC

    Jerusalem,
    Israel

    Site Not Available

  • Shaare Zedek MC

    Jerusalem,
    Israel

    Site Not Available

  • SzpitalKlinicznyPrzemienieniaPańskiegoUniwersytetuMedycznegoim. Karola Marcinkowskiego w Poznaniu

    Poznan,
    Poland

    Site Not Available

  • MedicoverOpiekaSzpitalna, AlejaRzeczypospolitej 5, 02-972

    Warsaw,
    Poland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.